Gene therapy for stroke: 2006 overview

Yi Chu, Jordan D. Miller, Donald D. Heistad

Research output: Contribution to journalReview article

11 Scopus citations

Abstract

Gene therapy is a promising approach for treatment of stroke and other cerebrovascular diseases, although it may take many years to realize. Gene therapy could occur prior to a stroke (eg, to stabilize atherosclerotic plaques) and/or following a stroke (eg, to prevent vasopasm after subarachnoid hemorrhage [SAH] or reduce injury to neurons by ischemic insult). We have transferred the gene coding for vasoactive calcitonin gene-related peptide via cerebrospinal fluid, and demonstrated attenuation of vasospasm after SAH. Transfer of neuroprotective genes or small interfering RNA for neurotoxic genes has good potential for ischemic stroke. In this brief report, we review recent developments in experimental gene therapy for stroke. Fundamental advances, including development of safer, more specific gene transfer vectors, are discussed.

Original languageEnglish (US)
Pages (from-to)19-24
Number of pages6
JournalCurrent Hypertension Reports
Volume9
Issue number1
DOIs
StatePublished - Mar 1 2007

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Gene therapy for stroke: 2006 overview'. Together they form a unique fingerprint.

  • Cite this